The purpose


The purpose of the foundation is to promote human health and better life, primarily in Sweden, but in other countries as well. 

The promotion of the purpose should preferably be through contributions to prevent and combat cancer diseases, to treat and care for cancer patients and to support cancer research.

The purpose of the foundation is to promote human health and better life, primarily in Sweden, but also in other countries. The purpose shall be furthered mainly through contributions that aim to prevent and combat cancer diseases, to treat and care for cancer patients and to support cancer research.

The working methods


The foundation will actively source research projects and other projects that are supported by the foundations ordinance. Stiftelsen Cancera respects your privacy and will protect all data which we process about you. All personal data are processed in accordance with applicable data protection laws. Please read our information sheet for more details about this.

Grants awarded

The foundation has awarded the following grants.

 

 

SEK 2,000,000 to Associate Professor Kristina Lundberg at the Faculty of Engineering at Lund University for the project "Tumour-infiltrating immune cells and their role in new immuno-oncology therapies".

 
 The need for new strategies to prompt an adequate immune response against tumour cells is enormous. By identifying and characterising new types of immune cells in solid tumours, the project will develop new ways to kick-start an immune response directed against the tumour cells. In this way, we can make it possible for more patients to benefit from the powerful and long-term effects achieved with this new type of drug. 

 

 

SEK 2,000,000 to Professor Kristian Pietras and Dr Alexander Pietras at Lund University for their project "Contribution of the tumour microenvironment to aggressive tumour growth and treatment resistance".

 
The aim of the project is to understand the mechanisms underlying treatment resistance and tumour progression in brain tumours, with the goal of finding new therapeutic targets in the tumour's microenvironment. 

 

 

 

SEK 2,000,000 to Dr Ulrika Axelsson at the Faculty of Engineering at Lund University for the project  "A molecular fingerprint of psychological resilience".

 
The purpose of the project is to identify a biomolecular signature which correlates with the degree of psychological resilience in breast cancer patients. This will open entirely new strategies for cancer treatments.

 

SEK 2,000,000 to Professor Sara Ek at the Faculty of Engineering at Lund University for the project "Early diagnosis of lung cancer".

 

Diagnosis of lung cancer at an early stage could save lives by means of surgical treatment. The possibilities of introducing digital tools to monitor early symptoms of lung cancer means that there is an absolute need for screening tools to meet the need to follow up on early symptoms of, among others, smokers. The goal of the project is to produce non-invasive, specific, and cost-efficient diagnostic tools which can complement current screening tools. 

 

 

EUR 35,000 to Centre Hospitalier du Luxembourg, Department General and Minimally Invasive Surgery for the project "Comparative study of prognostic markers in colorectal cancer" Under the supervision of Dr Martine Goergen-Azagra and Silviu-Tiberiu Makkai-Popa.

The aim of the project is to collect, analyse, and compare different factors which have an impact on the cancer tumour's prognosis, with the goal of optimising the treatment of cancer patients.

Board


Ida Järvegren, President

Bengt Johansson, Member

Andreas Klow, Member

Frans Henrik Kockum, Member